With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Marijuana Investing
Innovation Drives Value for Leading Cannabis Biotechs
As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates
India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions.
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis
InMed Pharmaceuticals, Inc. has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids.
From CFN - Exclusive CEO Interview: InMed Pharmaceuticals’ Biosynthesis Platform Results in an Industry First
CFN Media sits down for an exclusive interview with InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). (VIDEO)
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) Announce Profit Sharing Agreement with Cultivation Technologies, Inc.
FinCanna Capital Corp. and Astar Minerals Ltd. (TSX.V: TAR) this morning announced that FinCanna will share 50 percent of the profits from Cultivation Technologies’ interim medical cannabis extraction facility operating in Coachella, California.
Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory
EVIO, Inc. this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California.
Grey Cloak Tech, Inc. (GRCK) Announces Cancellation of Reverse Stock Split
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery
Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
India Globalization Capital, Inc. (NYSE: IGC) Enters MOU Related to Import and Distribution of Cannabinoid-Based Therapies in Germany
India Globalization Capital, Inc. (NYSE American: IGC) this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH.
Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences
Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction.
Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
Copy of Global Payout, Inc. (GOHE) Subsidiary Sells Front Cover of First PotSaver Los Angeles Edition
MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.